We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
501
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.64M | 0.02% |
32,733
+7,919
| +32% | +$585K |
|
502
ESAB
ESAB
$5.37B
| $2.63M | 0.02% |
+55,991
| New | +$2.34M |
|
503
Sanmina
SANM
$8.96B
| $2.61M | 0.02% |
45,642
-8,725
| -16% | -$516K |
|
504
LegalZoom.com
LZ
$1.45B
| $2.6M | 0.02% |
+336,310
| New | +$2.92M |
|
505
NBT Bancorp
NBTB
$2.81B
| $2.58M | 0.02% |
59,393
+290
| +0.5% | +$12.8K |
|
506
Spok Holdings
SPOK
$230M
| $2.56M | 0.02% |
312,046
+148,268
| +91% | +$1.2M |
|
507
Merchants Bancorp
MBIN
$2.51B
| $2.55M | 0.02% |
104,885
-3,044
| -3% | -$74.1K |
|
508
ARS Pharmaceuticals
SPRY
$569M
| $2.55M | 0.02% |
298,616
-152,218
| -34% | -$988K |
|
509
Pulmonx
LUNG
$52.8M
| $2.54M | 0.02% |
+301,083
| New | +$2.86M |
|
510
Tango Therapeutics
TNGX
$4.24B
| $2.51M | 0.02% |
346,471
+548
| +0.2% | +$3.85K |
|
511
Resources Connection
RGP
$139M
| $2.5M | 0.02% |
135,948
-19,297
| -12% | -$355K |
|
512
Great Southern Bancorp
GSBC
$882M
| $2.48M | 0.02% |
41,634
-2,409
| -5% | -$146K |
|
513
Tilly's
TLYS
$115M
| $2.47M | 0.02% |
273,287
-24,049
| -8% | -$211K |
|
514
Aviat Networks
AVNW
$255M
| $2.45M | 0.02% |
78,555
-55,068
| -41% | -$1.67M |
|
|
SMAR
515
DELISTED
Smartsheet Inc.
SMAR
| $2.42M | 0.02% |
61,538
-9,093
| -13% | -$310K |
|
516
CRA International
CRAI
$1.24B
| $2.42M | 0.02% |
19,764
-8,932
| -31% | -$984K |
|
517
Cardlytics
CDLX
$22.6M
| $2.4M | 0.02% |
+41,534
| New | +$2.57M |
|
518
Atea Pharmaceuticals
AVIR
$371M
| $2.4M | 0.02% |
499,058
+118,541
| +31% | +$600K |
|
|
TRUE
519
DELISTED
TrueCar
TRUE
| $2.4M | 0.02% |
955,994
-178,698
| -16% | -$372K |
|
520
Wyndham Hotels & Resorts
WH
$5.59B
| $2.4M | 0.02% |
33,644
-1,054
| -3% | -$74.5K |
|
521
Independent Bank Corp
IBCP
$799M
| $2.37M | 0.02% |
99,076
-38,704
| -28% | -$882K |
|
|
TRHC
522
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.37M | 0.02% |
478,157
-148,653
| -24% | -$612K |
|
523
Kodiak Sciences
KOD
$2.56B
| $2.35M | 0.02% |
328,608
+117,521
| +56% | +$843K |
|
524
Nurix Therapeutics
NRIX
$2.46B
| $2.34M | 0.02% |
213,081
+200,230
| +1,558% | +$2.41M |
|
525
HCI Group
HCI
$2.33B
| $2.33M | 0.02% |
58,906
-13,323
| -18% | -$491K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.